Publications
Follow along for our lab publications!
Love M, Toon D, Mocherniak A, et al. Rural Disadvantage in Glioblastoma Concentrates in the Early Postoperative Period: A Single-Center, Treatment-Standardized Cohort Study. Neuro-Oncology Practice. Published online May 25, 2026. doi:https://doi.org/10.1093/nop/npag045
Andrews K, Howran J, Quilty D, et al. Single-cell atlas of glioblastoma across the tumour-to-brain axis reveals the distinct cellular landscape of infiltrative disease. Research Square. Published online May 9, 2026. doi:https://doi.org/10.21203/rs.3.rs-9590848/v1
Sharma A, Andrews K, Calvert E, et al. Stakeholder Perspectives on Brain Tumor Care Across Rural-Urban Boundaries: A Reflexive Thematic Analysis. medRxiv. Published online March 11, 2026. doi:https://doi.org/10.64898/2026.03.10.26348065
Love M, Toon D, Mocherniak A, et al. Rural Disadvantage in Glioblastoma Concentrates in the Early Postoperative Period: A Single-Center, Treatment-Standardized Cohort Study. medRxiv. Published online January 8, 2026. doi:https://doi.org/10.64898/2026.01.06.26343534
Howran J, Andrews K, Ogawa K, et al. Distal noncontiguous recurrence and sarcomatous transformation of glioblastoma with stable molecular profile: illustrative case. Journal of Neurosurgery: Case Lessons. 2026;11(1). doi:https://doi.org/10.3171/case25714
Andrews K, Dejean H, MacLeod C, et al. Using Quality Function Deployment to Design an Image-Guided, Multibiopsy Tool for Neurosurgical Applications. Operative Neurosurgery. Published online July 3, 2025. doi:https://doi.org/10.1227/ons.0000000000001696
Sharma A, Ellis L, Andrews K, et al. Dexamethasone-Induced p57-Mediated Quiescence Drives Chemotherapy Resistance in Sonic Hedgehog Medulloblastoma. bioRxiv (Cold Spring Harbor Laboratory). Published online April 30, 2025. doi:https://doi.org/10.1101/2025.04.27.650711
Aalto T, Abacan M, Abadi S, et al. The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative. Cancer Cell. 2025;0(0). doi:10.1016/j.ccell.2025.03.014
Purzner J, Brown AS, Purzner T, et al. Ezh2 Delays Activation of Differentiation Genes During Normal Cerebellar Granule Neuron Development and in Medulloblastoma. eLife. Published online March 18, 2025. doi:https://doi.org/10.7554/elife.105339.1
Srikanthan D, Kaufmann M, Jamzad A, et al. Attention based multi-instance learning for improved glioblastoma detection using mass spectrometry. Linte CA, Siewerdsen JH, eds. Medical Imaging 2023: Image-Guided Procedures, Robotic Interventions, and Modeling. Published online April 3, 2023:34. doi:https://doi.org/10.1117/12.2654436
Yan M, Zalay O, Kennedy T, et al. Outcomes of Hypofractionated Stereotactic Radiotherapy for Small and Moderate-Sized Brain Metastases: A Single-Institution Analysis. Frontiers in Oncology. 2022;12. doi:https://doi.org/10.3389/fonc.2022.869572
Ye VC, Landry AP, Purzner T, et al. Adult isocitrate dehydrogenase–mutant brainstem glioma: illustrative case. Journal of neurosurgery Case lessons. 2021;1(12). doi:https://doi.org/10.3171/case2078
Zhong B, Campagne O, Salloum R, Purzner T, Stewart CF. LC-MS/MS method for quantitation of the CK2 inhibitor silmitasertib (CX-4945) in human plasma, CSF, and brain tissue, and application to a clinical pharmacokinetic study in children with brain tumors. Journal of Chromatography B. 2020;1152:122254-122254. doi:https://doi.org/10.1016/j.jchromb.2020.122254
Nitta RT, Bolin S, Luo E, et al. Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide. Oncogene. 2019;38(42):6867-6879. doi:https://doi.org/10.1038/s41388-019-0927-y
Purzner T, Purzner J, Buckstaff T, et al. Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma. Science Signaling. 2018;11(547). doi:https://doi.org/10.1126/scisignal.aau5147